HouseH.R. 10483119th Congress

Bone Marrow Radiation Shielding Act

Full Text

Official text as published. Use Ctrl+F / Cmd+F to search within the document.

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10483 Introduced in House (IH)]

<DOC>

119th CONGRESS
  2d Session
                               H. R. 10483

To direct the Assistant Secretary of Defense for Nuclear, Chemical, and 
   Biological Defense, Policy and Programs to seek to enter into an 
agreement with a University Affiliated Research Center affiliated with 
 United States Strategic Command to conduct an independent scientific 
assessment with respect to bone marrow radiation shielding for nuclear 
                             survivability.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 17, 2026

  Mr. Bacon introduced the following bill; which was referred to the 
                      Committee on Armed Services

_______________________________________________________________________

                                 A BILL

 
To direct the Assistant Secretary of Defense for Nuclear, Chemical, and 
   Biological Defense, Policy and Programs to seek to enter into an 
agreement with a University Affiliated Research Center affiliated with 
 United States Strategic Command to conduct an independent scientific 
assessment with respect to bone marrow radiation shielding for nuclear 
                             survivability.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Bone Marrow Radiation Shielding 
Act''.

SEC. 2. INDEPENDENT ASSESSMENT OF BONE MARROW RADIATION SHIELDING FOR 
              NUCLEAR SURVIVABILITY.

    (a) Assessment Required.--Not later than 30 days after the date of 
the enactment of this Act, the Assistant Secretary of Defense for 
Nuclear, Chemical, and Biological Defense, Policy and Programs shall 
seek to enter into an agreement with a University Affiliated Research 
Center affiliated with United States Strategic Command to conduct an 
independent scientific assessment on whether preserving the viability 
of bone marrow using partial body radiation shielding can improve the 
survivability of an individual exposed to gamma radiation as compared 
to an individual without such protection.
    (b) Elements.--The assessment required under subsection (a) shall 
examine peer-reviewed scientific literature, laboratory studies and 
relevant experimental data to evaluate the comparative effectiveness of 
preserving bone marrow using partial body radiation shielding with 
respect to--
            (1) the likelihood of developing Acute Radiation Syndrome;
            (2) the severity of Acute Radiation Syndrome when it 
        occurs; and
            (3) overall mortality rates following gamma radiation 
        exposure.
    (c) Report.--Not later than 150 days after the date of the 
enactment of this Act, the Assistant Secretary shall submit to the 
Committees on Armed Services of the House of Representatives and the 
Senate a report on the assessment required under subsection (a) that 
includes the findings of such assessment.
                                 <all>